IPG vs PBYI
IPG (IPG) versus Puma Biotechnology Inc (PBYI) — a side-by-side from cached financials, not a winner call.
IPG (IPG) common stock.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
IPG does not have a complete income-statement cache yet.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
Not investment advice. Open the IPG and PBYI stock pages for the full models.
Not investment advice.